Aster DM Healthcare Finalizes Quality Care Amalgamation, Expanding Equity Base to INR 8.7 Billion
Aster DM Healthcare Limited has successfully completed its merger with Quality Care India Limited (QCIL), marking a significant milestone in the company’s expansion strategy. The amalgamation is expected to strengthen Aster’s presence in India’s healthcare sector by combining the operational strengths, hospital networks, and healthcare capabilities of both organizations.
Following the completion of the merger process, the company’s Board of Directors approved the allotment of 353,551,410 new equity shares at its meeting held on July 13, 2026. The share allotment is in accordance with the Scheme of Amalgamation that received approval from the National Company Law Tribunal (NCLT) on June 19, 2026.
Share Exchange Details
As per the approved merger scheme:
- Shareholders of the erstwhile Quality Care India Limited have been allotted 977 fully paid-up equity shares of Aster DM Healthcare for every 1,000 equity shares held in QCIL.
- A total of 353,551,410 new equity shares, each having a face value of ₹10, have been issued.
- The newly allotted shares will rank pari passu with the existing equity shares of the company in all respects.
Expanded Equity Capital
The merger has significantly increased Aster DM Healthcare’s paid-up equity capital.
Before the merger:
- Paid-up Equity Capital: ₹518.12 crore
- Total Equity Shares: 518.12 million
After the merger:
- Paid-up Equity Capital: ₹871.67 crore
- Total Equity Shares: 871.67 million
The increase reflects the issuance of shares to QCIL shareholders under the approved swap ratio.
Listing on Stock Exchanges
The newly issued equity shares are proposed to be listed on both the BSE and the National Stock Exchange (NSE), providing shareholders with continued liquidity and ensuring compliance with regulatory requirements.
Strategic Significance of the Merger
The integration of Quality Care India represents a major strategic step for Aster DM Healthcare. The combined entity is expected to benefit from:
- A larger healthcare delivery network
- Greater operational efficiencies and cost synergies
- Expanded clinical capabilities and service offerings
- Stronger financial scale and market presence
- Enhanced opportunities for long-term growth
The merger is expected to improve Aster’s ability to serve a larger patient base while strengthening its competitive position in India’s rapidly growing healthcare industry.